Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current perspectives on antiretroviral therapy

C V Fletcher1

  • 1Department of Pharmacy Practice, College of Pharmacy, University of Minnesota, Minneapolis 55455.

Pharmacotherapy
|November 1, 1993
PubMed
Summary

Current human immunodeficiency virus (HIV) treatments focus on inhibiting reverse transcriptase, with zidovudine as the primary option for both asymptomatic and symptomatic infections. Alternative therapies exist for specific patient groups.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.

The Journal of antimicrobial chemotherapy·2020
Same author

Pharmacokinetics of tenofovir during pregnancy and postpartum.

HIV medicine·2015
Same author

Accelerator mass spectrometry measurement of intracellular concentrations of active drug metabolites in human target cells in vivo.

Clinical pharmacology and therapeutics·2010
Same author

Drug interactions should be evaluated in patients.

Clinical pharmacology and therapeutics·2010
Same author

Pharmacokinetics and pharmacodynamics of efavirenz and nelfinavir in HIV-infected children participating in an area-under-the-curve controlled trial.

Clinical pharmacology and therapeutics·2007
Same author

The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.

Clinical pharmacology and therapeutics·2007

Area of Science:

  • Virology
  • Infectious Diseases
  • Pharmacology

Background:

  • Over one million individuals in the U.S. are living with human immunodeficiency virus (HIV).
  • Understanding the HIV life cycle is crucial for developing effective antiviral therapies.
  • Inhibition of reverse transcriptase is a clinically validated strategy against HIV.

Purpose of the Study:

  • To review current therapeutic strategies for HIV infection.
  • To outline the role of reverse transcriptase inhibitors in HIV treatment.
  • To discuss alternative treatment options for patients with HIV.

Main Methods:

  • Review of existing literature on HIV treatment and reverse transcriptase inhibitors.
  • Analysis of current clinical guidelines for HIV management.
  • Identification of available antiviral drugs and their applications.

Main Results:

  • Zidovudine is the recommended first-line therapy for both asymptomatic and symptomatic HIV infection.
  • Didanosine and zalcitabine are available as monotherapy or combination therapy alternatives.
  • Treatment options are tailored for patients intolerant to, failing, or previously treated with zidovudine.

Conclusions:

  • Significant progress has been made in managing HIV infection through reverse transcriptase inhibitors.
  • Despite advancements, the progressive nature of HIV disease presents ongoing therapeutic challenges.
  • Continued research is essential to overcome the complexities of HIV treatment.

Related Experiment Videos